Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of the Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion.

Next Previous
Trial Profile

Evaluation of the Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion.

Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Conivaptan (Primary) ; Furosemide; Nesiritide
  • Indications Heart failure
  • Focus Therapeutic Use

Most Recent Events

  • 09 May 2011 Planned end date changed from 1 Jan 2010 to 1 Feb 2010 as reported by ClinicalTrials.gov.
  • 09 May 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
  • 23 Dec 2008 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top